Problem Before Product
We start with the regulated or operational problem—not a technology looking for a use case.

WHPL is a specialist Life Sciences technology company building software, AI Agents and intelligence systems for regulated clinical, evidence, regulatory and quality workflows.
Domain workflows · traceability · controlled intelligence
It must also be controlled, explainable and aligned with the way regulated work is actually performed. That is the environment WHPL is built for.
We combine Life Sciences domain understanding, software engineering, evidence architecture and AI-enabled intelligence to address operational and regulatory problems across clinical development and product-evidence lifecycles.
We start with the regulated or operational problem—not a technology looking for a use case.
AI matters when it improves a meaningful workflow, decision or business outcome.
In regulated environments, confidence must come from supporting evidence, not marketing promises.
Technology should strengthen expert decision-making rather than obscure responsibility.
When information contributes to an important conclusion, teams should understand where it came from and how it is connected.
Where commercially and technically appropriate, WHPL complements existing Life Sciences technology investments rather than requiring unnecessary replacement.
Domain workflows create the operating context. Connected evidence preserves the relationships. Intelligence helps professionals find, review and act on what matters.
Technology designed around clinical, regulatory, evidence and quality workflows.
Connect data, documents, claims, risks, conclusions and source information.
Use domain-specific AI and analytics to identify relevant information and improve evidence review.
WHPL is building toward a future where Life Sciences professionals spend less time finding, reconciling and reconstructing information—and more time approving the evidence that matters and making informed decisions.
That is what Regulated Intelligence and Agents for Life Sciences means to us.Start with the clinical, regulatory, evidence or quality problem—not a generic technology demonstration.